16-67185149-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178516.4(EXOC3L1):āc.1736A>Gā(p.Asn579Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00116 in 1,613,032 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178516.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EXOC3L1 | NM_178516.4 | c.1736A>G | p.Asn579Ser | missense_variant | 11/14 | ENST00000314586.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EXOC3L1 | ENST00000314586.11 | c.1736A>G | p.Asn579Ser | missense_variant | 11/14 | 2 | NM_178516.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000664 AC: 101AN: 152070Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000548 AC: 136AN: 248304Hom.: 0 AF XY: 0.000489 AC XY: 66AN XY: 134926
GnomAD4 exome AF: 0.00121 AC: 1772AN: 1460962Hom.: 1 Cov.: 32 AF XY: 0.00118 AC XY: 861AN XY: 726772
GnomAD4 genome AF: 0.000664 AC: 101AN: 152070Hom.: 0 Cov.: 33 AF XY: 0.000619 AC XY: 46AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.1736A>G (p.N579S) alteration is located in exon 11 (coding exon 10) of the EXOC3L1 gene. This alteration results from a A to G substitution at nucleotide position 1736, causing the asparagine (N) at amino acid position 579 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at